{Reference Type}: Journal Article
{Title}: [Interpretation of 2020 American Academy of Orthopaedic Surgeons (AAOS) on the Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline].
{Author}: You T;Zhang W;Li W;Zhang X;Jiang X;Zuo J;Zhou R;Chen J;Jiang C;
{Journal}: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
{Volume}: 35
{Issue}: 8
{Year}: Aug 2021 15
暂无{DOI}: 10.7507/1002-1892.202103088
{Abstract}: The 2020 Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline which was prepared by the American Academy of Orthopaedic Surgeons (AAOS) were publicated on October 2020. The guideline involves the following 8 chapters: drug therapy and injectable biologics, physical therapy and non-surgical treatments, radiographs, prognostic factors, surgical treatments, intraoperative hemostasis measure (tranexamic acid), management of supraspinatus tears, multimodal pain management and discharge. In this paper, the guideline is interpreted to provide cutting-edge information for domestic glenohumeral joint osteoarthritis researchers.<BR>2020 年 10 月，美国骨科医师学会（AAOS）发布了 2020 年肩关节骨关节炎管理的循证临床实践指南。该指南涉及 8 个方面内容：药物及生物制剂治疗、物理治疗和其他非手术治疗、影像学检查、预后因素、手术治疗、术中止血措施（氨甲环酸）、合并冈上肌腱撕裂的处理、术后镇痛及出院管理。现对该指南进行解读，以期为国内肩关节骨关节炎研究者提供最前沿信息。.